Otsuka and Astex’s oral Inaqovi wins European approval for AML

European Commission has approved the oral combination drug for treating newly diagnosed acute myeloid leukaemia.

Sep 19, 2023 - 20:00

Otsuka and Astex’s oral Inaqovi wins European approval for AML

European Commission has approved the oral combination drug for treating newly diagnosed acute myeloid leukaemia.

Read the original article

Tags:

Previous Article

Overcoming disruptions in the pharmaceutical supply chain

60 Degrees pauses Phase IIB Covid-19 trial for tafenoquine

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

A plot to solve the ‘whack-a-mole’ of drug discovery

A plot to solve the ‘whack-a-mole’ of drug discovery

Dec 13, 2023

Drugmakers push back on a clever tactic employers use to avoid paying for specialty medicines

Drugmakers push back on a clever tactic employers use t...

Mar 22, 2023

EC approves Daiichi Sankyo’s Vanflyta for acute myeloid leukaemia

EC approves Daiichi Sankyo’s Vanflyta for acute myeloid...

Nov 12, 2023